Strata Skin Sciences (SSKN) Earns Daily Coverage Optimism Score of 0.26
News stories about Strata Skin Sciences (NASDAQ:SSKN) have trended positive recently, according to Accern. The research firm scores the sentiment of media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Strata Skin Sciences earned a news sentiment score of 0.26 on Accern’s scale. Accern also gave media headlines about the medical device company an impact score of 44.4118405209703 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
Several research analysts have recently weighed in on the stock. ValuEngine raised shares of Strata Skin Sciences from a “strong sell” rating to a “sell” rating in a report on Friday, June 16th. Zacks Investment Research cut shares of Strata Skin Sciences from a “hold” rating to a “sell” rating in a report on Wednesday, August 16th. Finally, HC Wainwright reissued a “buy” rating on shares of Strata Skin Sciences in a report on Thursday, September 7th.
Shares of Strata Skin Sciences (SSKN) traded up 0.57% during mid-day trading on Friday, reaching $1.76. 3,415 shares of the company traded hands. The firm has a 50-day moving average price of $1.74 and a 200 day moving average price of $2.12. Strata Skin Sciences has a 52 week low of $1.43 and a 52 week high of $5.40. The firm’s market capitalization is $4.36 million.
Strata Skin Sciences (NASDAQ:SSKN) last posted its quarterly earnings results on Thursday, August 10th. The medical device company reported ($0.52) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.71) by $0.19. Strata Skin Sciences had a negative net margin of 18.00% and a negative return on equity of 41.58%. The company had revenue of $8.70 million during the quarter, compared to analyst estimates of $7.98 million. On average, analysts anticipate that Strata Skin Sciences will post ($3.14) earnings per share for the current year.
About Strata Skin Sciences
STRATA Skin Sciences, Inc, formerly MELA Sciences, Inc, is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging.
Receive News & Ratings for Strata Skin Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Skin Sciences Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.